IGF1R and hepatocellular carcinoma: Analysis of miR-122 and IGF-1R expression in tissue samples from HCC patients shows that miR-122 is found at low levels in patients resistant to sorafenib treatment compared to those patients sensitive to this TKI, while IGF-1R levels are high in sorafenib-resistant patients [104].